Comparing Ocrevus vs Rituxan
Ocrevus | Rituxan |
|
---|
Ocrevus (ocrelizumab) | Rituxan (rituximab) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Ocrevus is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate, reducing inflammation in people with MS. After an initial loading dose, it is given by IV infusion every... View more |
Prescription only
Rituxan is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid... View more |
||||||||||||||||
More about Ocrevus (ocrelizumab) | More about Rituxan (rituximab) | ||||||||||||||||
Generic Status | |||||||||||||||||
No lower-cost generic available |
No lower-cost generic available |
||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Ocrevus has an average rating of 4.6 out of 10 from a total of 155 ratings on Drugs.com. 34% of reviewers reported a positive effect, while 51% reported a negative effect. |
Rituxan has an average rating of 8.0 out of 10 from a total of 38 ratings on Drugs.com. 78% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: Ocrevus side effects in more detail. |
See also: Rituxan side effects in more detail. |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Ocrevus prices |
View all Rituxan prices |
||||||||||||||||
Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
Other rituximab brands include: Riabni, Ruxience, Truxima | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
624 hours |
59.8 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 392 drugs are known to interact with Ocrevus:
|
A total of 166 drugs are known to interact with Rituxan:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
March 28, 2017 |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.